Watch 6:59
Britain approves a COVID-19 vaccine, raising questions about a U.S. rollout
Britain’s approval Wednesday of Pfizer's COVID vaccine dialed up the anticipation, pressures and questions about vaccines in the U.S. and how the distribution will be handled. William Brangham spoke with Dr. Moncef Slaoui, chief scientific officer for the federal government's…
The Latest: First US immunizations could arrive on Dec. 12
A Food and Drug Administration advisory committee is set to meet Dec. 10 to discuss Pfizer Inc.’s request for an emergency use authorization for its developing COVID-19 vaccine.
Pfizer seeking emergency use of its COVID-19 vaccine in U.S.
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic…
Pfizer to seek emergency coronavirus vaccine approval
Pharmaceutical companies Pfizer and BioNTech will seek emergency government approval for their coronavirus vaccine, as the U.S. aims to begin administering doses by the end of the year.
Joe Biden’s scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump’s refusal to acknowledge that he lost the election. That delayed handoff is especially problematic during a public…
The drug company Pfizer announced Monday that early data indicates its COVID-19 vaccine could be highly effective. Their candidate is only one of a number in development, and it’s quite possible the world will ultimately need several vaccines made by…
A statement from a group of CEOs, no matter how powerful, won’t fundamentally change how they operate. But there’s one thing that will.
In our news wrap Friday, pharmaceutical giant Pfizer -- the last remaining federally approved supplier of lethal injection drugs -- announced it will no longer allow its products to be used for executions. Also, Russian President Vladimir Putin stepped up…
The Obama administration has taken steps to rein in big businesses this week: New rules issued by the Treasury Department regarding tax loopholes ended a $160 billion deal between Pfizer and Allergan. Meanwhile, the Justice Department has filed an antitrust…
Additional Support Provided By:
